Overexpression of a Transporter Gene in a Multidrug-Resistant Human Lung Cancer Cell Line
The DOI matches its Crossref record; 47 of the 47 references it cites were found in a registry or an index.
Abstract
The doxorubicin-selected lung cancer cell line H69AR is resistant to many chemotherapeutic agents. However, like most tumor samples from individuals with this disease, it does not overexpress P-glycoprotein, a transmembrane transport protein that is dependent on adenosine triphosphate (ATP) and is associated with multidrug resistance. Complementary DNA (cDNA) clones corresponding to messenger RNAs (mRNAs) overexpressed in H69AR cells were isolated. One cDNA hybridized to an mRNA of 7.8 to 8.2 kilobases that was 100- to 200-fold more expressed in H69AR cells relative to drug-sensitive parental H69 cells. Overexpression was associated with amplification of the cognate gene located on chromosome 16 at band p13.1. Reversion to drug sensitivity was associated with loss of gene amplification and a marked decrease in mRNA expression. The mRNA encodes a member of the ATP-binding cassette transmembrane transporter superfamily.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“The overexpression of ABCC1 in tumor cells has been implicated in the multidrug-resistant phenotype caused by cytotoxic drugs (60).”
From SRC kinase drives multidrug resistance induced by KRAS-G12C inhibition (2024) · cites this paper as [60]
In the citing paper
“ABCC1, which was originally cloned from the human small cell lung cancer cell line H69AR (60), is known to transport a variety of endogenous substrates, such as the antioxidant glutathione and pro-inflammatory leukotrienes (65).”
From SRC kinase drives multidrug resistance induced by KRAS-G12C inhibition (2024) · cites this paper as [60]
In the citing paper
“To date, at least 15 human ABC superfamily transporters, including ABCB1 (59), ABCC1 (60), and ABCG2 (61), have been reported to mediate multidrug resistance in different circumstances, including G12Ci treatment (27, 62, 63).”
From SRC kinase drives multidrug resistance induced by KRAS-G12C inhibition (2024) · cites this paper as [60]
Citations
Cites
DNA sequencing with chain-terminating inhibitors
Sanger, F., Nicklen, S., & Coulson, A. R. (1977) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.74.12.5463 · Cited by 68,572
A technique for radiolabeling DNA restriction endonuclease fragments to high specific activity
Feinberg, A. P., & Vogelstein, B. (1983) · Analytical Biochemistry · doi:10.1016/0003-2697(83)90418-9 · Cited by 24,887
A comprehensive set of sequence analysis programs for the VAX
Devereux, J., Haeberli, P., & Smithies, O. (1984) · Nucleic Acids Research · doi:10.1093/nar/12.1part1.387 · Cited by 14,222
Improved tools for biological sequence comparison.
Pearson, W. R., & Lipman, D. J. (1988) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.85.8.2444 · Cited by 11,227
Identification of the Cystic Fibrosis Gene: Cloning and Characterization of Complementary DNA
Riordan, J. R., Rommens, J. M., Kerem, B.-S., Alon, N., Rozmahel, R., Grzelczak, Z., Zielenski, J., Lok, S., Plavsic, N., Chou, J.-L., et al. (1989) · Science · doi:10.1126/science.2475911 · Cited by 7,418
Walker, J. E., Saraste, M., Runswick, M. J., & Gay, N. J. (1982) · The EMBO Journal · doi:10.1002/j.1460-2075.1982.tb01276.x · Cited by 5,312
Thiebaut, F., Tsuruo, T., Hamada, H., Gottesman, M. M., Pastan, I., & Willingham, M. C. (1987) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.84.21.7735 · Cited by 2,777
Chen, C.-J., Chin, J. E., Ueda, K., Clark, D. P., Pastan, I., Gottesman, M. M., & Roninson, I. B. (1986) · Cell · doi:10.1016/0092-8674(86)90595-7 · Cited by 1,898
Progressive sequence alignment as a prerequisitetto correct phylogenetic trees
Feng, D.-F., & Doolittle, R. F. (1987) · Journal of Molecular Evolution · doi:10.1007/bf02603120 · Cited by 1,883
Cordon-Cardo, C., O'Brien, J. P., Casals, D., Rittman-Grauer, L., Biedler, J. L., Melamed, M. R., & Bertino, J. R. (1989) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.86.2.695 · Cited by 1,750
Research works printed but not linked: 3
- GERLACH, J.H., MULTIDRUG RESISTANCE, CANCER SURVEYS 5: 25 (1986).
- UEYAMA, H, STRUCTURE OF A HUMAN SMOOTH-MUSCLE ACTIN GENE (AORTIC TYPE) WITH A UNIQUE INTRON SITE, MOLECULAR AND CELLULAR BIOLOGY 4: 1073 (1984).
- VANDERBLIEK, A.M., OVEREXPRESSION AND AMPLIFICATION OF 5 GENES IN A MULTIDRUG-RESISTANT CHINESE-HAMSTER OVARY CELL-LINE, MOLECULAR AND CELLULAR BIOLOGY 6: 1671 (1986).
Cited by
Items 1,001–1,012 of 1,012
Involvement of multidrug resistance proteins (MDR) in the modulation of glucocorticoid response
Webster, J. I., & Carlstedt‐Duke, J. (2002) · The Journal of Steroid Biochemistry and Molecular Biology · doi:10.1016/s0960-0760(02)00227-3 · Cited by 60
A Structure-Based View on ABC-Transporter Linked to Multidrug Resistance
(2023) · doi:10.3390/molecules28020495 · Cited by 48
“managed to clone a cDNA encoding a specific transporter protein of 170 kDa, and termed it multidrug resistance related protein 1 (MRP1) [5].”
BackgroundMicroRNA-27a reduces mutant hutingtin aggregation in an in vitro model of Huntington's disease
Ban, J.-J., Chung, J.-Y., Lee, M., Im, W., & Kim, M. (2017) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2017.05.040 · Cited by 36
miR-133b down-regulates ABCC1 and enhances the sensitivity of CRC to anti-tumor drugs
Chen, M., Li, D., Gong, N., Wu, H., Su, C., Xie, C., Xiang, H., Lin, C., & Li, X. (2017) · Oncotarget · doi:10.18632/oncotarget.17677 · Cited by 35
Pharmacogenetics‐Based New Therapeutic Concepts
Roots, I., Gerloff, T., Meisel, C., Kirchheiner, J., Goldammer, M., Kaiser, R., Laschinski, G., Brockmöller, J., Cascorbi, I., Kleeberg, U., et al. (2004) · Drug Metabolism Reviews · doi:10.1081/dmr-200033458 · Cited by 33
“The multidrug resistance-related protein MRP1 (ABCC1) is also able to confer multiple resistance against diverse anticancer agents (Cole et al., 1992).”
BackgroundConseil, G., & Cole, S. P. C. (2013) · Drug Metabolism and Disposition · doi:10.1124/dmd.113.054213 · Cited by 28
“amplification of its cognate ABCC1 gene that was associated with a 100-fold increase in mRNA relative to its drug sensitive parental cell line (Cole et al., 1992).”
BackgroundSelf-citationSRC kinase drives multidrug resistance induced by KRAS-G12C inhibition
Song, X., Zhou, Z., Elmezayen, A., Wu, R., Yu, C., Gao, B., Minna, J. D., Westover, K. D., Zeh, H. J., Kroemer, G., et al. (2024) · Science Advances · doi:10.1126/sciadv.adq4274 · Cited by 26
Wang, Y., Tu, M.-J., & Yu, A.-M. (2024) · Frontiers in Pharmacology · doi:10.3389/fphar.2024.1423416 · Cited by 21
“Anthracyclines Doxorubicin (Mechetner et al., 1998) 2.”
BackgroundInfluentialZhang, W., Oh, J.-H., Zhang, W., Rathi, S., Le, J., Talele, S., Sarkaria, J. N., & Elmquist, W. F. (2023) · Pharmaceutical Research · doi:10.1007/s11095-023-03574-1 · Cited by 19
“The multidrug resistance-associated protein (MRPs, ABCC) family has multiple members, of which MRP1 was the first ABC transporter involved in multidrug resistance identified in a multidrug-resistant human lung cancer cell line [64, 65].”
Celestino, A. T., Levy, D., Maria Ruiz, J. L., & Bydlowski, S. P. (2015) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2015.01.045 · Cited by 19
A model explaining mRNA level fluctuations based on activity demands and RNA age
Xu, Z., & Asakawa, S. (2021) · PLOS Computational Biology · doi:10.1371/journal.pcbi.1009188 · Cited by 9
Intact-cell MALDI-ToF mass spectrometry for the authentication of drug-adapted cancer cell lines
Povey, J. F., Saintas, E., Aderemi, A. V., Rothweiler, F., Zehner, R., Dirks, W. G., Cinatl, J., Racher, A. J., Wass, M. N., Smales, C. M., et al. (2019) · Cells · doi:10.3390/cells8101194 · Cited by 5
“The ATP-binding cassette (ABC) transporters ABCB1 (also known as P-glycoprotein or MDR1) and ABCC1 (also known as MRP1), major mediators of drug resistance in cancer, were discovered in drug-adapted cell lines [31,32].”
Background
Metadata
- Authors
- Cole, S. P. C., Bhardwaj, G., Gerlach, J. H., Mackie, J. E., Grant, C. E., Almquist, K. C., Stewart, A. J., Kurz, E. U., Duncan, A. M. V., & Deeley, R. G.
- Affiliations
- Queen's University (CA)
- Venue
- Science
- Published
- 1992-12-04
- Volume
- 258
- Issue
- 5088
- Pages
- 1650-1654
- ISSN
- 0036-8075 (ISSN-L)
- 1095-9203
- OpenAlex
- W2168070336
- Cited by
- 3,037
- References
- 47
- Citations by year
- 2026: 12 · 2025: 30 · 2024: 46 · 2023: 55 · 2022: 40 · 2021: 53 · 2020: 61 · 2019: 39 · 2018: 45 · 2017: 55 · 2016: 66 · 2015: 67 · 2014: 79 · 2013: 80 · 2012: 77
- FWCI
- 37.07
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- Science (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Health Sciences › Medicine › Oncology › Drug Transport and Resistance Mechanisms
- Health Sciences › Medicine › Microbiology (medical) › Antibiotic Resistance in Bacteria
- Life Sciences › Pharmacology, Toxicology and Pharmaceutics › Pharmacology › Pharmacogenetics and Drug Metabolism
- Keywords
- multidrug resistance, lung cancer, doxorubicin resistance, ABC transporters, gene amplification, P-glycoprotein, mRNA overexpression, cDNA cloning
- MeSH terms
- Amino Acid Sequence, Animals, Chromosome Banding, Chromosomes, Human, Pair 16, Doxorubicin, Drug Resistance, Gene Amplification, Multigene Family, Humans, Lung, Lung Neoplasms, Male, Membrane Glycoproteins, Molecular Sequence Data, Phylogeny, RNA, Messenger, Testis, Tumor Cells, Cultured, Sequence Homology, Amino Acid, ATP Binding Cassette Transporter, Subfamily B, Member 1
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.